Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OSL/LYTIX stock hub

OSL/LYTIX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/LYTIXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

834.4M

Oslo Børs

Market data

Live price

Current market quote for this ticker.

Current price

OSL/LYTIX

In the news

Latest news · OSL/LYTIX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-70.7

P25 n/aP50 n/aP75 n/a

ROIC-45.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/LYTIX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

NOK

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	14
Employees Change	3%
Employees Change Percent	27.27
Enterprise value	NOK 764.2M
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Biotechnology
Isin	NO0010405780
Last refreshed	2026-05-10
Market cap	NOK 834.4M
Price	NOK 10.85
Price currency	NOK
Sector	Healthcare
Sic	2836
Symbol	osl/LYTIX
Website	https://www.lytixbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.19%
EV Earnings	-12.74x
P/B ratio	13.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	NOK -60M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	NOK -4.3M
ROA	-35.09
Roa5y	-39.18
ROCE	-101.7
ROE	-70.72
Roe5y	-72.78
ROIC	-45.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	98.09%
Cagr3y	16.85%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	NOK 81.5M
Cash	NOK 72.4M
Current Assets	NOK 79.4M
Current Liabilities	NOK 18.6M
Debt	NOK 2.2M
Debt Equity	NOK 0.04
Equity	NOK 61.8M
Interest Coverage	-303.5
Liabilities	NOK 19.8M
Long Term Assets	NOK 2.1M
Long Term Liabilities	NOK 1.2M
Net Cash	NOK 70.2M
Net Cash By Market Cap	NOK 8.41
Net Cash Growth	-45.25%
Net Debt Equity	NOK -1.14
Tangible Book Value	NOK 61.8M
Tangible Book Value Per Share	NOK 0.9
WACC	1.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.28
Net Working Capital	NOK -10.5M
Quick ratio	4.23
Working Capital	NOK 60.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	97.99%
200-day SMA	9.25
3Y total return	59.56%
50-day SMA	10.2
50-day SMA vs 200-day SMA	50over200
All Time High	21.5
All Time High Change	-49.53%
All Time High Date	2021-06-14
All Time Low	4.55
All Time Low Change	138.46%
All Time Low Date	2025-04-09
ATR	0.51
Beta	-0.5
Beta1y	0.03
Beta2y	0.19
Ch YTD	9.82
High	10.95
High52	11.9
High52 Date	2026-04-10
High52ch	-8.82%
Low	10.6
Low52	5.06
Low52 Date	2025-05-12
Low52ch	114.43%
Ma50ch	6.36%
Price vs 200-day SMA	17.31%
RSI	62.57
RSI Monthly	60.05
RSI Weekly	62.54
Sharpe ratio	1.41x
Sortino ratio	2.55
Total Return	-26.05%
Tr YTD	9.82
Tr1m	4.83%
Tr1w	6.37%
Tr3m	13.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -64M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,789,046%
Net Borrowing	-900,000
Shares Insiders	4.51%
Shares Institutions	14.76%
Shares Out	76,900,005
Shares Yo Y	26.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	66,209.35x
Bv Per Share	0.9
Ch1m	4.83
Ch1w	6.37
Ch1y	97.99
Ch3m	13.97
Ch3y	59.56
Ch6m	14.94
Change	2.36%
Change From Open	-0.91
Close	10.6
Days Gap	3.3
Depreciation Amortization	37,000
Dollar Volume	184,276.4
Earnings Date	2026-05-21
EBIT	NOK -64M
EBITDA	NOK -64M
EPS	NOK -0.88
F Score	2
Financing CF	-908,000
Fiscal Year End	December
Founded	2,003
Investing CF	-59,431,000
Is Primary Listing	1
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Ma150	9.53
Ma150ch	13.86%
Ma20	10.34
Ma20ch	4.95%
Net CF	-120,189,000
Next Earnings Date	2026-05-21
Open	10.95
Position In Range	71.43
Ppne	2,087,000
Price Date	2026-05-08
Ptbv Ratio	13.51
Relative Volume	0.26x
Share Based Comp	13,838,000
Tr6m	14.94%
Volume	16,984

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OSL/LYTIX pay a dividend?

Capital-return profile for this ticker.

Performance

OSL/LYTIX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OSL/LYTIX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.8%

Share of float held by funds and institutions

Insider ownership

+4.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+26.1%

Negative means the company is buying back shares.

Technical

OSL/LYTIX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.6

Neutral momentum band

Price vs 200-day MA

+17.3%

50/200-day relationship not available

Beta (5Y)

-0.50

Less volatile than the market

Sharpe ratio

1.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/LYTIX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/LYTIX stock rating?

osl/LYTIX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/LYTIX analysis?

The full report lives at /stocks/osl/LYTIX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/LYTIX?

The latest report frames osl/LYTIX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/LYTIX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.